Policy Perspective

Oct 31, 2018

The COGR F&A Paper: October 2018 Meeting

Financial Management & Compliance

F&A

Comment Letter

Policy Perspective

Oct 10, 2018

Final Joint Association Comments on Proposed Changes to the NIH Guidelines on Recombinant or Synthetic Nucleic Acid Research

Document

Biosafety & Related Research Issues

Research Compliance

Comment Letter

Policy Perspective

Sep 20, 2018

COGR Submits Letter to DEA Regarding Production Quotas for Schedule I & II Controlled Substances

COGR submitted formal comments to the U.S. Drug Enforcement Administration (DEA) regarding the proposed 2019 aggregate production quotas for Schedule I and II controlled substances, with particular attention to marijuana and its derivatives. COGR expressly supports the proposed increase in production quotas for marijuana and tetrahydrocannabinols, seeing this as a constructive move to advance scie

Cannabis/Controlled Substances

Research Compliance

Comment Letter

Policy Perspective

Sep 20, 2018

COGR Submission to DOT on NABR Complaint

Document

Animal Subjects

Research Compliance

Policy Perspective

Sep 20, 2018

Factors that Influence Facilities & Administrative Cost Rates at Research Intensive Universities: June 1998

COGR Memo on Variations in Administrative Cost Rates of Research – A Look at 8 Universities

Financial Management & Compliance

F&A

Policy Perspective

Sep 20, 2018

Action Items for the Streamlining Working Group

The document outlines the action items of the Streamlining Working Group, aimed at enhancing efficiency and harmonization among foundations and research institutions in key administrative areas. The group plans to form specialized sub-groups focusing on (A) portal and application/proposal systems, (B) financial reporting and invoicing, and (C) common policies and terms such as data sharing and con

Proposals & Awards

Policy Perspective

Jul 27, 2018